Phosphatidylserine, Lion's Mane, and the Nootropic Hierarchy That Actually Has Evidence
Cutting through the $4 billion nootropics market: the compounds with peer-reviewed human trial data, the ones with only rodent studies, and the ones with neither — mapped against their mechanism of action and realistic effect sizes.